Midazolam oral - Primex Pharmaceuticals

Drug Profile

Midazolam oral - Primex Pharmaceuticals

Alternative Names: ADV 6209; Ozaline

Latest Information Update: 07 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Advicenne
  • Developer Primex Pharmaceuticals
  • Class Benzodiazepines; Hypnosedatives; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Anaesthesia; Sedation

Most Recent Events

  • 07 Mar 2017 Chemical structure information added
  • 05 Oct 2016 Preregistration for Anaesthesia (In children, In infants, In adolescents) in France, Finland, United Kingdom, Netherlands, Italy (PO)
  • 05 Oct 2016 Preregistration for Sedation (In adolescents, In children, In infants) in France, Finland, United Kingdom, Netherlands, Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top